<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Int J Mol Sci</journal-id><journal-id journal-id-type="publisher-id">ijms</journal-id><journal-title-group><journal-title>International Journal of Molecular Sciences</journal-title></journal-title-group><issn pub-type="epub">1422-0067</issn><publisher><publisher-name>Molecular Diversity Preservation International (MDPI)</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.3390/ijms11052188</article-id><article-id pub-id-type="publisher-id">ijms-11-02188</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Apoptotic Effects of Chrysin in Human Cancer Cell Lines</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Khoo</surname><given-names>Boon Yin</given-names></name><xref ref-type="corresp" rid="c1-ijms-11-02188">*</xref></contrib><contrib contrib-type="author"><name><surname>Chua</surname><given-names>Siang Ling</given-names></name></contrib><contrib contrib-type="author"><name><surname>Balaram</surname><given-names>Prabha</given-names></name></contrib><aff id="af1-ijms-11-02188">Institute for Research in Molecular Medicine (INFORMM), Universiti Sains Malaysia, 11800 USM, Penang, Malaysia; E-Mails: 
<email>siang_ling85@yahoo.com</email> (S.L.C.); 
<email>prabha@kb.usm.my</email> (P.B.)</aff></contrib-group><author-notes><corresp id="c1-ijms-11-02188"><label>*</label>Author to whom correspondence should be addressed; E-Mail: 
<email>boonyin@usm.my</email>; Tel.: +604-653-4819; Fax: +604-653-4803.</corresp></author-notes><pub-date pub-type="epub"><day>19</day><month>5</month><year>2010</year></pub-date><pub-date pub-type="collection"><year>2010</year></pub-date><volume>11</volume><issue>5</issue><fpage>2188</fpage><lpage>2199</lpage><history><date date-type="received"><day>23</day><month>3</month><year>2010</year></date><date date-type="rev-recd"><day>3</day><month>5</month><year>2010</year></date><date date-type="accepted"><day>6</day><month>5</month><year>2010</year></date></history><permissions><copyright-statement>&#x000a9; 2010 by the authors; licensee Molecular Diversity Preservation International, Basel, Switzerland.</copyright-statement><copyright-year>2010</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p><!--CREATIVE COMMONS-->This article is an open-access article distributed under the terms and conditions of the Creative Commons Attribution license (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/">http://creativecommons.org/licenses/by/3.0/</ext-link>).</license-p></license></permissions><abstract><p>Chrysin is a natural flavonoid currently under investigation due to its important biological anti-cancer properties. In most of the cancer cells tested, chrysin has shown to inhibit proliferation and induce apoptosis, and is more potent than other tested flavonoids in leukemia cells, where chrysin is likely to act via activation of caspases and inactivation of Akt signaling in the cells. Moreover, structure-activity relationships have revealed that the chemical structure of chrysin meets the key structural requirements of flavonoids for potent cytotoxicity in leukemia cells. It is possible that combination therapy or modified chrysin could be more potent than single-agent use or administration of unmodified chrysin. This study may help to develop ways of improving the effectiveness of chrysin in the treatment of leukemia and other human cancers <italic>in vitro</italic>.</p></abstract><kwd-group><kwd>chrysin</kwd><kwd>apoptotic effect</kwd><kwd>human cancers</kwd><kwd><italic>in vitro</italic></kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><label>1.</label><title>Introduction of Flavonoids</title><p>Flavonoids are a broad class of plant pigments that are ubiquitously present in fruit- and vegetable-derived foods [<xref ref-type="bibr" rid="b1-ijms-11-02188">1</xref>,<xref ref-type="bibr" rid="b2-ijms-11-02188">2</xref>]. Flavonoids can be easily ingested and a high level of flavonoids in food has been identified as an important constituent of the human diet. More than 4,000 types of biologically active flavonoids have been identified [<xref ref-type="bibr" rid="b3-ijms-11-02188">3</xref>], which can be further divided into flavonols, flavones, flavanols, flavanones, anthocyanidins and isoflavonoid subclasses [<xref ref-type="bibr" rid="b4-ijms-11-02188">4</xref>]. Chrysin, which is the focus of this review, is a flavone. The flavones have a common chemical structure, consisting of fused A and C rings, and a phenyl B ring attached to position 2 of the C ring (<xref ref-type="fig" rid="f1-ijms-11-02188">Figure 1A</xref>). Flavones, such as apigenin, baicalein, chrysin and scutellarein, were recently identified as having important biological roles in nitrogen fixation and chemical defenses [<xref ref-type="bibr" rid="b3-ijms-11-02188">3</xref>&#x02013;<xref ref-type="bibr" rid="b11-ijms-11-02188">11</xref>].</p><p>Among the flavonoids studied, apigenin [5,7-dihydroxy-2-(4-hydroxyphenyl)-4<italic>H</italic>-chromen-4-one] has shown a remarkable inhibitory effect on cancer cell growth in both <italic>in vitro</italic> and <italic>in vivo</italic> tumor models [<xref ref-type="bibr" rid="b12-ijms-11-02188">12</xref>,<xref ref-type="bibr" rid="b13-ijms-11-02188">13</xref>]. Apigenin also possesses anti-inflammatory and free radical scavenging properties in several cancer cell lines [<xref ref-type="bibr" rid="b14-ijms-11-02188">14</xref>,<xref ref-type="bibr" rid="b15-ijms-11-02188">15</xref>], and inhibits tumor cell invasion, metastasis [<xref ref-type="bibr" rid="b16-ijms-11-02188">16</xref>], mitogen-activated protein kinases (MAPKs) and its downstream oncogenes [<xref ref-type="bibr" rid="b17-ijms-11-02188">17</xref>]. Chrysin (5,7-dihydroxy-2-phenyl-4H-chromen-4-one) is an analog of apigenin [<xref ref-type="bibr" rid="b18-ijms-11-02188">18</xref>,<xref ref-type="bibr" rid="b19-ijms-11-02188">19</xref>], but its anti-cancer properties have rarely been studied. Chrysin shares the common flavone structure with additional hydroxyls at positions 5 and 7 of the A ring (<xref ref-type="fig" rid="f1-ijms-11-02188">Figure 1B</xref>). Chrysin has recently shown to be a potent inhibitor of aromatase [<xref ref-type="bibr" rid="b18-ijms-11-02188">18</xref>] and of human immunodeficiency virus activation in models of latent infection [<xref ref-type="bibr" rid="b20-ijms-11-02188">20</xref>]. It has also demonstrated anti-inflammatory [<xref ref-type="bibr" rid="b21-ijms-11-02188">21</xref>] and anti-oxidant effects [<xref ref-type="bibr" rid="b22-ijms-11-02188">22</xref>], and has shown cancer chemopreventive activity via induction of apoptosis in diverse range of human and rat cell types. However, studies of the effects of chrysin on human cancers remain rare.</p><p>Activation of apoptosis is the key molecular mechanism responsible for the anti-cancer activities of most of the currently studied potential anti-cancer agents, including chrysin. Apoptosis contrasts with cell necrosis, in which the cells suffer a major insult, resulting in loss of membrane integrity, swelling and disruption [<xref ref-type="bibr" rid="b23-ijms-11-02188">23</xref>]. During necrosis, the cellular contents are uncontrollably released into the extracellular environment, causing damage to surrounding cells and a strong inflammatory response in the corresponding tissues. In contrast, apoptosis induces cell shrinkage, chromatin condensation and margination at the nuclear periphery, with the eventual formation of membrane-bound apoptotic bodies containing organelles, cytosol and nuclear fragments, which are then phagocytosed without triggering inflammatory processes in the surrounding tissues. Although the chemical structure of chrysin with only two hydroxyls at position 5 and 7 of A ring showed lower cytotoxicity activity in certain human cancer cells, the potential apoptotic effect of chrysin has been reported in human cervical cancer, leukemia, esophageal squamous carcinoma, malignant glioma, breast carcinoma, prostate cancer, non-small cell lung cancer (NSCLC) and colon cancer <italic>in vitro</italic>, as outlined in <xref ref-type="table" rid="t1-ijms-11-02188">Table 1</xref>.</p></sec><sec><label>2.</label><title>Chrysin Inhibits Proliferation and Induces Apoptosis in HeLa Cells</title><p>A study by Zhang <italic>et al</italic>. [<xref ref-type="bibr" rid="b24-ijms-11-02188">24</xref>] demonstrated that chrysin and its derivatives [diethyl chrysin-7-yl phosphate (CPE: C<sub>19</sub>H<sub>19</sub>O<sub>7</sub>P) and tetraethyl bis-phosphoric ester of chrysin (CP: C<sub>23</sub>H<sub>28</sub>O<sub>10</sub>P<sub>2</sub>)] exhibited potential anti-cancer effects in human cervical carcinoma. The chemical structures showed that CPE and CP have phosphate groups at positions 5 and/or 7 of the A ring, respectively (<xref ref-type="fig" rid="f1-ijms-11-02188">Figure 1C</xref> and <xref ref-type="fig" rid="f1-ijms-11-02188">1D</xref>), which replace the hydroxyls at positions 5 and/or 7 of the A ring in chrysin. According to this study, chrysin and phosphorylated chrysin effectively inhibited the growth of cervical cancer cells, HeLa, via apoptosis induction and down-regulated the proliferating cell nuclear antigen (PCNA) in the cells. However, how the chrysin improved the resistant of TRAIL-induced apoptosis in HeLa cells was not mentioned in this study. Another study showed that chrysin potentially induced p38, therefore activated NFkappaB/p65 in the HeLa cells [<xref ref-type="bibr" rid="b25-ijms-11-02188">25</xref>]. The MAPK p38 pathway has been implicated in the regulation of a wide spectrum of cellular processes, including cell-cycle arrest and apoptosis. Besides, it has been regarded as a potential phosphate donor for the p65 subunit of NFkappaB. According to the study [<xref ref-type="bibr" rid="b25-ijms-11-02188">25</xref>], treatment of HeLa cells with 30 &#x003bc;M chrysin for 24 h induced a significant increase of NFkappaB/p65 levels in the cells, as demonstrated by EMSA. The signals could be suppressed by a specific p38 or p65 inhibitor indicating that the p38 or p65 could be useful therapeutic targets of chrysin to control gene expression in HeLa cells. However, no correlation of pro-apoptotic or apoptotic activity induced by chrysin in this phenomenon was clearly stated in the study. Although, chrysin was found to significantly sensitize the TNFalpha-induced apoptosis in human colorectal cancer cell line HCT-116, human liver cancer cell line HepG2, and the human nasopharyngeal carcinoma cell line CNE-1, in which such sensitization is closely associated with inhibitory effect on NFkappaB activation, the phenomenon may occur differently in HeLa cells [<xref ref-type="bibr" rid="b35-ijms-11-02188">35</xref>]. Therefore, the NFkappaB remains a potential target to study the mechanism of apoptosis induced by chrysin in HeLa cells.</p><p>Although both chrysin and phosphorylated chrysin could inhibit proliferation and induced apoptosis in HeLa cells, as mentioned above, the effects of the phosphorylated chrysins were likely more potent than that of non-phosphorylated chrysin, where the estimated IC<sub>50</sub> for chrysin was 14.2 &#x003bc;M, followed by CPE (IC<sub>50</sub> = 10.3 &#x003bc;M) and CP (IC<sub>50</sub> = 9.8 &#x003bc;M), assessed by the cell viability assays [<xref ref-type="bibr" rid="b24-ijms-11-02188">24</xref>]. Phosphorylated chrysin(s), which could easily form non-covalent compound with lysozyme, are thus concluded as more effective in inhibiting cancer cell growth and inducing apoptosis than non-phosphorylated chrysin in HeLa cells.</p></sec><sec><label>3.</label><title>Chrysin Induces Apoptosis in Leukemia Cells</title><p>In one study, 22 different flavonoids and related compounds were screened in human leukemia cells, U937. Among the flavonoids tested, genistein, apigenin, alpha-naphto-flavone, chrysin, quercetin, galangin, luteolin, fisetin and 3,7-dihydroxyflavone were found to significantly reduce the cellular viability of the U937 cells. However, only apigenin, chrysin, quercetin, galangin, luteolin and fisetin were found to clearly induce the oligonucleosomal DNA fragmentation at 50 &#x003bc;M after 6 h of treatment [<xref ref-type="bibr" rid="b26-ijms-11-02188">26</xref>]. Chrysin was the most effective flavonoid in terms of reducing the viability of the U937 cells with an IC<sub>50</sub> of 16 &#x003bc;M. Chrysin also potentiated the effects of TNFalpha in triggering apoptosis in the cells. On the other hand, Woo <italic>et al</italic>. [<xref ref-type="bibr" rid="b27-ijms-11-02188">27</xref>] showed that chrysin induced apoptosis in association with activation of caspase-3, involving inactivation of Akt or Protein Kinases B (PKB) signaling and down-regulation of X-linked inhibitor of apoptosis protein (XIAP) in the U937 cells. This study provided the first evidence of a more detailed molecular mechanism whereby chrysin induces the apoptosis in leukemia cells namely via Akt dephosphorylation of the phosphoinositide 3 kinase (PI3K) signaling pathway.</p><p>The Akt signaling pathway, from PI3K to phosphoinositide-dependent kinase-1 (PDK1) and from PDK1 to Akt, mediates apoptosis in human cancer cells (<xref ref-type="fig" rid="f2-ijms-11-02188">Figure 2</xref>). Activation of Akt via phosphorylation prevents apoptosis [<xref ref-type="bibr" rid="b36-ijms-11-02188">36</xref>], whereas dephosphorylation is likely to initiate apoptosis. Phosphorylation of Akt phosphorylates BAD (Bcl-2-associated death protein) and a non-active form of caspase-9, which are the hosts of the cell-signaling proteins. Phosphorylated BAD binds to cytosolic 14-3-3 proteins, resulting in a failure of the protein to heterodimerize with Bcl-2 at the mitochondrial membrane [<xref ref-type="bibr" rid="b37-ijms-11-02188">37</xref>]. Dephosphorylation of BAD releases BAD from cytosolic 14-3-3 proteins, which subsequently form heterodimers with Bcl-2 family proteins and migrate into the mitochondrial membrane, where they induce the release of cytochrome <italic>c</italic> by altering the membrane pores [<xref ref-type="bibr" rid="b38-ijms-11-02188">38</xref>,<xref ref-type="bibr" rid="b39-ijms-11-02188">39</xref>]. Cytochrome <italic>c</italic> in the cytoplasm combines with Apaf-1 and caspase-9 to form a complex termed an apoptosome, in the presence of ATP, in order to activate the caspase-9 [<xref ref-type="bibr" rid="b39-ijms-11-02188">39</xref>]. The caspase-9 subsequently activates the downstream executor caspase-3. Activation of caspase-3 and the subsequent degradative events probably trigger apoptosis [<xref ref-type="bibr" rid="b39-ijms-11-02188">39</xref>,<xref ref-type="bibr" rid="b40-ijms-11-02188">40</xref>]. Conversely, phosphorylation of caspase-9 by phosphorylated Akt prevents formation of the apoptosome complex, and therefore the downstream event of apoptosis is inhibited.</p><p>Woo <italic>et al</italic>. [<xref ref-type="bibr" rid="b27-ijms-11-02188">27</xref>] noted several important effects of chrysin in U937 cells: (1) chrysin mediated the release of cytochrome <italic>c</italic> from mitochondria into the cytoplasm; (2) chrysin induced elevated caspase-3 activity and proteolytic cleavage of its downstream targets, such as phospholipase C-gamma-1 (PLC-gamma1), which is correlated with down-regulation of XIAP; and (3) chrysin decreased phosphorylated Akt levels in cells where the PI3K pathway plays a role in regulating the mechanism. These results suggested that chrysin-induced apoptosis was likely to be caspase- and mitochondria-dependent, and probably occurs via deregulation of PI3K/Akt, with involvement of XIAP. However, no measurement of BAD protein levels was reported in this study. The results of this study are in agreement with many other studies showing that chrysin, alone or in combination with other compounds, decreased the Akt phosphorylation and potentially resulted in mitochondrial dysfunction in leukemia cells [<xref ref-type="bibr" rid="b28-ijms-11-02188">28</xref>,<xref ref-type="bibr" rid="b30-ijms-11-02188">30</xref>]. Chrysin has also been reported to have the ability to abolish the stem cell factor (SCF)/c-Kit signaling by inhibiting the PI3K pathway [<xref ref-type="bibr" rid="b29-ijms-11-02188">29</xref>]. In addition, Monasterio <italic>et al</italic>. [<xref ref-type="bibr" rid="b26-ijms-11-02188">26</xref>] reported that flavonoids, including chrysin, induced apoptosis via a mechanism that required the activation of caspase-3 and caspase-8, indicating that chrysin-induced apoptosis could act via a ligand receptor-dependent cell death mechanism. This study also suggested a relationship between Akt and NFkappaB signaling in the cells. However, more studies are warranted to further evaluate the relationship of Akt and NFkappaB in the chrysin-treated leukemia cells.</p><p>A significant decrease in human telomerase reverse transcriptase (hTERT) expression levels was also observed in leukemia cells treated with 60 ng/mL <italic>Manisa propolis</italic>, owing to its constituent of chrysin [<xref ref-type="bibr" rid="b41-ijms-11-02188">41</xref>]. Other studies, such as that of Josipovic and Orsolic [<xref ref-type="bibr" rid="b42-ijms-11-02188">42</xref>], demonstrated that chrysin (as well as quercetin and caffeic acid) showed a high level of cytotoxicity in leukemia cells. The methanol extracts of apigenin, baicalein, chrysin, luteolin and wogonin have also shown a strong anti-leukemic activity [<xref ref-type="bibr" rid="b43-ijms-11-02188">43</xref>]. All these studies indicated that chrysin exhibited potential anti-leukemic activities, suggesting its use as a potential anti-leukemic agent. The proliferation inhibitory effects of most of the flavonoids, including chrysin, in leukemia cells appear to be dose-dependent [<xref ref-type="bibr" rid="b44-ijms-11-02188">44</xref>]. Moreover, structure-activity relationship studies reveal that the chemical structure of chrysin, which consists of a 2,3-double bond of C ring, a B ring attached to C ring at position 2, appropriate hydroxyls at position 5 and 7 of A ring, are likely to meet the key structural requirements of flavonoids for potent cytotoxicity in leukemia cells [<xref ref-type="bibr" rid="b26-ijms-11-02188">26</xref>].</p></sec><sec><label>4.</label><title>Cytotoxicity of Chrysin in Esophageal Squamous Carcinoma</title><p>The cytotoxic effects of structurally related flavones (luteolin, apigenin, chrysin) and flavonols (quercetin, kaempferol, myricetin), as well as the molecular mechanisms responsible for the cytotoxic effects in a human esophageal squamous cell carcinoma cell line, KYSE-510, have been determined by Zhang <italic>et al</italic>. [<xref ref-type="bibr" rid="b32-ijms-11-02188">32</xref>]. The results of MTT assays showed that chrysin, as well as other flavonoids tested, were able to induce the cytotoxicity in KYSE-510 cells in dose- and time-dependent manners. Chrysin was estimated to have an IC<sub>50</sub> of 63 &#x003bc;M in the cell line. Flow cytometry and DNA fragmentation analyses indicated that the cytotoxicity induced by chrysin (80 &#x003bc;M) and other flavonoids for 24 h was mediated by G(2)/M cell cycle arrest and apoptosis. Furthermore, the study revealed that treatment of KYSE-510 cells with chrysin (and other flavonoids) caused G(2)/M arrest through up-regulation of p21(waf1) and down-regulation of cyclin B1 at the mRNA and protein levels. In addition, the induction of apoptosis was p53-independent, but mitochondria-mediated through an up-regulation of p53-inducible gene 3 (PIG3) and cleavage of caspase-9 and caspase-3. The results of western blot analysis further showed that the increases in p63 and p73 translation or stability might contribute to the regulation of p21(waf1), cyclin B1 and PIG3 in the chrysin-induced KYSE-510 cells.</p></sec><sec><label>5.</label><title>Chrysin in Malignant Glioma, Breast Carcinoma, Prostate and Other Human Cancers</title><p>In a study by Parajuli <italic>et al</italic>. [<xref ref-type="bibr" rid="b11-ijms-11-02188">11</xref>], chrysin exhibited tumor-specific effects in diverse range of human cell lines, including malignant glioma cells (U87-MG and U-251), breast carcinoma cells (MDA-MB-231) and prostate cancer cells (PC3). Chrysin and other flavonoids (apigenin, baicalein, baicalin, scutellarein and wogonin) extracted from <italic>Scutellaria</italic> plants, showed dose-dependent inhibition of U87-MG proliferation. Apigenin was the most potent flavonoid, with IC<sub>30</sub>, IC<sub>50</sub> and IC<sub>70</sub> of approximately 16 &#x003bc;M, 62 &#x003bc;M and 250 &#x003bc;M, respectively, compared to IC<sub>30</sub>, IC<sub>50</sub> and IC<sub>70</sub> for chrysin of approximately 40 &#x003bc;M, 100 &#x003bc;M and 200 &#x003bc;M, respectively. This study also found that all six flavonoids, including chrysin (100 &#x003bc;M), significantly inhibited the proliferation of MDA-MB-231 cells, where a significant 43% inhibition was observed following treatment with chrysin. Chrysin also significantly inhibited the proliferation of U-251 and PC3 cells at 100 &#x003bc;M concentrations. All flavonoids examined, except scutellarein, also displayed significantly higher apoptotic activity in U87-MG cells compared to untreated U87-MG cells. The induction of apoptosis was significantly enhanced by increasing the dose of flavonoids, and further enhanced by prolonging treatment time from 72 h to 96 h. In this case, baicalein and baicalin produced the highest levels of apoptosis in U87-MG cells, followed by wogonin, apigenin, chrysin and scutellarein (not statistically significant), in accordance. However, the study did not report any details regarding the apoptotic activity of chrysin and other flavonoids in U-251, MDA-MB-231 and PC3 cells.</p><p>Other studies have reported the effects of chrysin, including in NSCLC and colon carcinoma. For example, chrysin (and wogonin), have been reported to have potential as adjuvant therapy for drug-resistant NSCLC, especially in patients with AKR1C1/1C2 overexpression [<xref ref-type="bibr" rid="b33-ijms-11-02188">33</xref>]. This study evaluated the effect of flavonoids and demonstrated that IL-6-induced AKR1C1/1C2 overexpression and drug resistance can be inhibited by chrysin and wogonin, which both demonstrated multiple anti-inflammatory effects in these cells. Chrysin has also been demonstrated to cause SW480 cells to arrest at the G2/M phase of the cell-cycle in a dose-dependent manner [<xref ref-type="bibr" rid="b34-ijms-11-02188">34</xref>]. Combining chrysin with apigenin was found to double the proportion of SW480 cells in G2/M. Thus, apigenin-related flavonoids such as chrysin, may cooperatively protect against colorectal cancer through conjoint blocking of cell-cycle progression. Chrysin also inhibited the lipopolysaccharide-induced COX-2 expression via inhibition of nuclear factor IL-6 (NF-IL6) [<xref ref-type="bibr" rid="b45-ijms-11-02188">45</xref>]. Thus, chrysin might also improve the drug sensitivity of cancer cells by modulating the signaling pathways of inflammatory cytokines.</p><p>Perhaps the biological activities of chrysin could be improved by combination with other flavonoids, as combinations of flavonoids have been demonstrated to have better apoptotic effects than individual use of chrysin. For example, the combination of chrysin with apigenin, baicalin and scutellarein (5 &#x003bc;M each) inhibited the proliferation of U87-MG glioma cells by almost 50%, while chrysin alone showed no anti-proliferative activity in these cells [<xref ref-type="bibr" rid="b11-ijms-11-02188">11</xref>].</p><p>Besides, modified chrysin is demonstrated to exhibit more potent anti-cancer effects than the unmodified chrysin. In addition to the inhibitory effects of phosphorylated chrysin in HeLa cells, as mentioned above, 5-allyl-7-gen-difluoromethylenechrysin (ADFMChR) has shown to inhibit the proliferation of human ovarian cancer cells, CoC1, in a dose-dependent manner (IC<sub>50</sub> of 7.76 &#x003bc;mol/L) [<xref ref-type="bibr" rid="b46-ijms-11-02188">46</xref>]. The ADFMChR significantly induced apoptosis in this cell line in a concentration-dependent manner, with rates of apoptosis of 33.07% and 73.70% after the cells were treated with 10.0 and 30.0 &#x003bc;mol/L of ADFMChR, respectively, for 48 h. The apoptosis rate was compared with the cells treated with 10.0 and 30.0 &#x003bc;mol/L of unmodified chrysin, which rates the apoptosis of 21.70% and 40.00%, respectively. Moreover, another study investigating the effects of 5,7-dihydroxy-8-nitrochrysin (NOChR) on apoptosis in human gastric carcinoma cell line, SGC-7901, showed that NOChR markedly inhibited the proliferation of SGC-7901 cells in a dose-dependent manner, where the potency of NOChR (IC<sub>50</sub> of 4.14 &#x003bc;mol/L) was 10 times higher than that of unmodified chrysin (IC<sub>50</sub> of 40.56-&#x003bc;mol/L) [<xref ref-type="bibr" rid="b47-ijms-11-02188">47</xref>]. Overall, all these studies suggest that modified chrysin could exhibit more potent anti-cancer effects than the unmodified chrysin.</p><p>It is also possible that the potency of chrysin is improved by addition of more hydroxyl constituents. According to Monasterio <italic>et al</italic>. [<xref ref-type="bibr" rid="b26-ijms-11-02188">26</xref>], at least two hydroxyls at positions 3, 5 or 7 of the A ring were needed to confer the pro-apoptotic activity. This phenomenon can be seen in 4&#x02032;,7-dihydroxyflavone, chrysin and galangin where the 4&#x02032;,7-dihydroxyflavone has only one hydroxyl at position 7 of the A ring did not show pro-apoptotic activity, whereas the chrysin (which has two hydroxyls at positions 5 and 7 of the A ring) and galangin (which has three hydroxyls at positions 3, 5 and 7 of the A ring) have higher pro-apoptotic activity, in accordance. Moreover, the hydroxyls at 3&#x02032; and/or 4&#x02032; positions of the B ring are to increase the pro-apoptotic activity of the flavanoids, according to the study. However, the number of hydroxyl constituents in the B ring is not a good marker of the potential pro-apoptotic activity. Flavanoids that are not hydroxylated in the B ring, such as chrysin and galangin, are potent inducers of apoptosis. Introduction of hydroxyls may also lead to disturbance of the structure of flavanoids.</p></sec><sec sec-type="conclusions"><label>6.</label><title>Conclusions</title><p>Chrysin inhibits proliferation and induces apoptosis in most cancer cells tested, and is likely more potent than other flavonoids in leukemia cells. Studies of the mechanism of action suggest that the chrysin is likely to act via caspase activation and inactivation of the Akt signaling. The biological activities of chrysin, perhaps, may be improved by combination with other flavonoids and modifications to the structure of chrysin. Although most studies support the conclusion that chrysin induces apoptosis in various tumor cell lines, the mechanism of induction of apoptosis remains unclear. Studies published so far are often haphazard and sometimes contradictory. Therefore, more studies are warranted to identify the potential molecule target of chrysin involved in the modulation of apoptosis in human cancer <italic>in vitro</italic>.</p></sec></body><back><ack><p>The authors would like to thank the USM short-term grant (304/CIPPM/638153) for supporting the preparation of this manuscript.</p></ack><ref-list><title>References and Notes</title><ref id="b1-ijms-11-02188"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Robards</surname><given-names>K</given-names></name><name><surname>Antolovich</surname><given-names>M</given-names></name></person-group><article-title>Analytical chemistry of fruit bioflavonoids: A review</article-title><source>Analyst</source><year>1997</year><volume>122</volume><fpage>11</fpage><lpage>34</lpage></mixed-citation></ref><ref id="b2-ijms-11-02188"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pietta</surname><given-names>PG</given-names></name></person-group><article-title>Flavonoids as anti-oxidants</article-title><source>J. Nat. Prod</source><year>2000</year><volume>63</volume><fpage>1035</fpage><lpage>1042</lpage><pub-id pub-id-type="pmid">10924197</pub-id></mixed-citation></ref><ref id="b3-ijms-11-02188"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nijveldt</surname><given-names>RJ</given-names></name><name><surname>van Nood</surname><given-names>E</given-names></name><name><surname>van Hoorn</surname><given-names>DE</given-names></name><name><surname>Boelens</surname><given-names>PG</given-names></name><name><surname>van Norren</surname><given-names>K</given-names></name><name><surname>van Leeuwen</surname><given-names>PA</given-names></name></person-group><article-title>Flavonoids: A review of probable mechanisms of action and potential applications</article-title><source>Am. J. Clin. Nutr</source><year>2001</year><volume>74</volume><fpage>418</fpage><lpage>425</lpage><pub-id pub-id-type="pmid">11566638</pub-id></mixed-citation></ref><ref id="b4-ijms-11-02188"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kale</surname><given-names>A</given-names></name><name><surname>Gawande</surname><given-names>S</given-names></name><name><surname>Kotwal</surname><given-names>S</given-names></name></person-group><article-title>Cancer phytotherapeutics: role for flavonoids at the cellular level</article-title><source>Phytother. Res</source><year>2008</year><volume>22</volume><fpage>567</fpage><lpage>577</lpage><pub-id pub-id-type="pmid">18398903</pub-id></mixed-citation></ref><ref id="b5-ijms-11-02188"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Awad</surname><given-names>R</given-names></name><name><surname>Arnason</surname><given-names>JT</given-names></name><name><surname>Trudeau</surname><given-names>V</given-names></name><name><surname>Bergeron</surname><given-names>C</given-names></name><name><surname>Budzinski</surname><given-names>JW</given-names></name><name><surname>Foster</surname><given-names>BC</given-names></name><name><surname>Merali</surname><given-names>Z</given-names></name></person-group><article-title>Phytochemical and biological analysis of skullcap (Scutellaria lateriflora L.): A medicinal plant with anxiolytic properties</article-title><source>Phytomedicine</source><year>2003</year><volume>10</volume><fpage>640</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">14692724</pub-id></mixed-citation></ref><ref id="b6-ijms-11-02188"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Meng</surname><given-names>WD</given-names></name><name><surname>Xu</surname><given-names>YY</given-names></name><name><surname>Cao</surname><given-names>JG</given-names></name><name><surname>Qing</surname><given-names>FL</given-names></name></person-group><article-title>Synthesis and anti-cancer effect of chrysin derivatives</article-title><source>Bioorg. Med. Chem. Lett</source><year>2003</year><volume>13</volume><fpage>881</fpage><lpage>884</lpage><pub-id pub-id-type="pmid">12617913</pub-id></mixed-citation></ref><ref id="b7-ijms-11-02188"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>E</given-names></name></person-group><article-title>Herbal remedies for anxiety - a systematic review of controlled clinical trials</article-title><source>Phytomedicine</source><year>2006</year><volume>13</volume><fpage>205</fpage><lpage>208</lpage><pub-id pub-id-type="pmid">16428031</pub-id></mixed-citation></ref><ref id="b8-ijms-11-02188"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>WH</given-names></name><name><surname>Lee</surname><given-names>AR</given-names></name><name><surname>Yang</surname><given-names>CH</given-names></name></person-group><article-title>Anti-oxidative and anti-inflammatory activities of polyhydroxyflavonoids of Scutellaria baicalensis GEORGI</article-title><source>Biosci. Biotechnol. Biochem</source><year>2006</year><volume>70</volume><fpage>2371</fpage><lpage>2380</lpage><pub-id pub-id-type="pmid">17031041</pub-id></mixed-citation></ref><ref id="b9-ijms-11-02188"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Scheck</surname><given-names>AC</given-names></name><name><surname>Perry</surname><given-names>K</given-names></name><name><surname>Hank</surname><given-names>NC</given-names></name><name><surname>Clark</surname><given-names>WD</given-names></name></person-group><article-title>Anti-cancer activity of extracts derived from the mature roots of Scutellaria baicalensis on human malignant brain tumor cells</article-title><source>BMC Complement Altern. Med</source><year>2006</year><volume>6</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">16914050</pub-id></mixed-citation></ref><ref id="b10-ijms-11-02188"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cole</surname><given-names>IB</given-names></name><name><surname>Cao</surname><given-names>J</given-names></name><name><surname>Alan</surname><given-names>AR</given-names></name><name><surname>Saxena</surname><given-names>PK</given-names></name><name><surname>Murch</surname><given-names>SJ</given-names></name></person-group><article-title>Comparisons of Scutellaria baicalensis, Scutellaria lateriflora and Scutellaria racemosa: Genome size, anti-oxidant potential and phytochemistry</article-title><source>Planta Med</source><year>2008</year><volume>74</volume><fpage>474</fpage><lpage>481</lpage><pub-id pub-id-type="pmid">18484546</pub-id></mixed-citation></ref><ref id="b11-ijms-11-02188"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Parajuli</surname><given-names>P</given-names></name><name><surname>Joshee</surname><given-names>N</given-names></name><name><surname>Rimando</surname><given-names>AM</given-names></name><name><surname>Mittal</surname><given-names>S</given-names></name><name><surname>Yadav</surname><given-names>AK</given-names></name></person-group><article-title><italic>In vitro</italic> anti-tumor mechanisms of various Scutellaria extracts and constituent flavonoids</article-title><source>Planta Med</source><year>2009</year><volume>75</volume><fpage>41</fpage><lpage>48</lpage><pub-id pub-id-type="pmid">19031366</pub-id></mixed-citation></ref><ref id="b12-ijms-11-02188"><label>12.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Duthie</surname><given-names>G</given-names></name><name><surname>Crozier</surname><given-names>A</given-names></name></person-group><article-title>Plant-derived phenolic anti-oxidants</article-title><source>Curr. Opin. Clin. Nutr. Metab. Care</source><year>2000</year><volume>3</volume><fpage>447</fpage><lpage>451</lpage><pub-id pub-id-type="pmid">11085830</pub-id></mixed-citation></ref><ref id="b13-ijms-11-02188"><label>13.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Birt</surname><given-names>DF</given-names></name><name><surname>Hendrich</surname><given-names>S</given-names></name><name><surname>Wang</surname><given-names>W</given-names></name></person-group><article-title>Dietary agents in cancer prevention: Flavonoids and isoflavonoids</article-title><source>Pharmacol. Ther</source><year>2001</year><volume>90</volume><fpage>157</fpage><lpage>177</lpage><pub-id pub-id-type="pmid">11578656</pub-id></mixed-citation></ref><ref id="b14-ijms-11-02188"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>HK</given-names></name><name><surname>Cheon</surname><given-names>BS</given-names></name><name><surname>Kim</surname><given-names>YH</given-names></name><name><surname>Kim</surname><given-names>SY</given-names></name><name><surname>Kim</surname><given-names>HP</given-names></name></person-group><article-title>Effects of naturally occurring flavonoids on nitric oxide production in the macrophage cell line RAW 264.7 and their structure-activity relationships</article-title><source>Biochem. Pharmacol</source><year>1999</year><volume>58</volume><fpage>759</fpage><lpage>765</lpage><pub-id pub-id-type="pmid">10449184</pub-id></mixed-citation></ref><ref id="b15-ijms-11-02188"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Raso</surname><given-names>GM</given-names></name><name><surname>Meli</surname><given-names>R</given-names></name><name><surname>Di Carlo</surname><given-names>G</given-names></name><name><surname>Pacilio</surname><given-names>M</given-names></name><name><surname>Di Carlo</surname><given-names>R</given-names></name></person-group><article-title>Inhibition of inducible nitric oxide synthase and cyclooxygenase-2 expression by flavonoids in macrophage J774A.1</article-title><source>Life Sci</source><year>2001</year><volume>68</volume><fpage>921</fpage><lpage>931</lpage><pub-id pub-id-type="pmid">11213362</pub-id></mixed-citation></ref><ref id="b16-ijms-11-02188"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lindenmeyer</surname><given-names>F</given-names></name><name><surname>Li</surname><given-names>H</given-names></name><name><surname>Menashi</surname><given-names>S</given-names></name><name><surname>Soria</surname><given-names>C</given-names></name><name><surname>Lu</surname><given-names>H</given-names></name></person-group><article-title>Apigenin acts on the tumor cell invasion process and regulates protease production</article-title><source>Nutr. Cancer</source><year>2001</year><volume>39</volume><fpage>139</fpage><lpage>147</lpage><pub-id pub-id-type="pmid">11588896</pub-id></mixed-citation></ref><ref id="b17-ijms-11-02188"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuo</surname><given-names>ML</given-names></name><name><surname>Yang</surname><given-names>NC</given-names></name></person-group><article-title>Reversion of v-H-ras-transformed NIH 3T3 cells by apigenin through inhibiting mitogen activated protein kinase and its downstream oncogenes</article-title><source>Biochem. Biophys. Res. Commun</source><year>1995</year><volume>212</volume><fpage>767</fpage><lpage>775</lpage><pub-id pub-id-type="pmid">7626110</pub-id></mixed-citation></ref><ref id="b18-ijms-11-02188"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanderson</surname><given-names>JT</given-names></name><name><surname>Hordijk</surname><given-names>J</given-names></name><name><surname>Denison</surname><given-names>MS</given-names></name><name><surname>Springsteel</surname><given-names>MF</given-names></name><name><surname>Nantz</surname><given-names>MH</given-names></name><name><surname>van den Berg</surname><given-names>M</given-names></name></person-group><article-title>Induction and inhibition of aromatase (CYP19) activity by natural and synthetic flavonoid compounds in H295R human adrenocortical carcinoma cells</article-title><source>Toxicol. Sci</source><year>2004</year><volume>82</volume><fpage>70</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">15319488</pub-id></mixed-citation></ref><ref id="b19-ijms-11-02188"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weng</surname><given-names>MS</given-names></name><name><surname>Ho</surname><given-names>YS</given-names></name><name><surname>Lin</surname><given-names>JK</given-names></name></person-group><article-title>Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: Involvement of p38 mitogen-activated protein kinase</article-title><source>Biochem. Pharmacol</source><year>2005</year><volume>69</volume><fpage>1815</fpage><lpage>1827</lpage><pub-id pub-id-type="pmid">15869744</pub-id></mixed-citation></ref><ref id="b20-ijms-11-02188"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Critchfield</surname><given-names>JW</given-names></name><name><surname>Butera</surname><given-names>ST</given-names></name><name><surname>Folks</surname><given-names>TM</given-names></name></person-group><article-title>Inhibition of HIV activation in latently infected cells by flavonoid compounds</article-title><source>AIDS Res. Hum. Retroviruses</source><year>1996</year><volume>12</volume><fpage>39</fpage><lpage>46</lpage><pub-id pub-id-type="pmid">8825617</pub-id></mixed-citation></ref><ref id="b21-ijms-11-02188"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cho</surname><given-names>H</given-names></name><name><surname>Yun</surname><given-names>CW</given-names></name><name><surname>Park</surname><given-names>WK</given-names></name><name><surname>Kong</surname><given-names>JY</given-names></name><name><surname>Kim</surname><given-names>KS</given-names></name><name><surname>Park</surname><given-names>Y</given-names></name><name><surname>Lee</surname><given-names>S</given-names></name><name><surname>Kim</surname><given-names>BK</given-names></name></person-group><article-title>Modulation of the activity of pro-inflammatory enzymes, COX-2 and iNOS, by chrysin derivatives</article-title><source>Pharmacol. Res</source><year>2004</year><volume>49</volume><fpage>37</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">14597150</pub-id></mixed-citation></ref><ref id="b22-ijms-11-02188"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woodman</surname><given-names>OL</given-names></name><name><surname>Chan</surname><given-names>E</given-names></name></person-group><article-title>Vascular and anti-oxidant actions of flavonols and flavones</article-title><source>Clin. Exp. Pharmacol. Physiol</source><year>2004</year><volume>31</volume><fpage>786</fpage><lpage>790</lpage><pub-id pub-id-type="pmid">15566394</pub-id></mixed-citation></ref><ref id="b23-ijms-11-02188"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gewies</surname><given-names>A</given-names></name></person-group><article-title>Introduction to apoptosis</article-title><source>ApoReview</source><year>2003</year><fpage>1</fpage><lpage>26</lpage></mixed-citation></ref><ref id="b24-ijms-11-02188"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>T</given-names></name><name><surname>Chen</surname><given-names>X</given-names></name><name><surname>Qu</surname><given-names>L</given-names></name><name><surname>Wu</surname><given-names>J</given-names></name><name><surname>Cui</surname><given-names>R</given-names></name><name><surname>Zhao</surname><given-names>Y</given-names></name></person-group><article-title>Chrysin and its phosphate ester inhibit cell proliferation and induce apoptosis in Hela cells</article-title><source>Bioorg. Med. Chem</source><year>2004</year><volume>12</volume><fpage>6097</fpage><lpage>6105</lpage><pub-id pub-id-type="pmid">15519155</pub-id></mixed-citation></ref><ref id="b25-ijms-11-02188"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>von Brandenstein</surname><given-names>MG</given-names></name><name><surname>Ngum Abety</surname><given-names>A</given-names></name><name><surname>Depping</surname><given-names>R</given-names></name><name><surname>Roth</surname><given-names>T</given-names></name><name><surname>Koehler</surname><given-names>M</given-names></name><name><surname>Dienes</surname><given-names>HP</given-names></name><name><surname>Fries</surname><given-names>JW</given-names></name></person-group><article-title>A p38&#x02013;p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells</article-title><source>Biochim. Biophys. Acta</source><year>2008</year><volume>1783</volume><fpage>1613</fpage><lpage>1622</lpage><pub-id pub-id-type="pmid">18457675</pub-id></mixed-citation></ref><ref id="b26-ijms-11-02188"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Monasterio</surname><given-names>A</given-names></name><name><surname>Urdaci</surname><given-names>MC</given-names></name><name><surname>Pinchuk</surname><given-names>IV</given-names></name><name><surname>Lopez-Moratalla</surname><given-names>N</given-names></name><name><surname>Martinez-Irujo</surname><given-names>JJ</given-names></name></person-group><article-title>Flavonoids induce apoptosis in human leukemia U937 cells through caspase- and caspase-calpain-dependent pathways</article-title><source>Nutr. Cancer</source><year>2004</year><volume>50</volume><fpage>90</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">15572302</pub-id></mixed-citation></ref><ref id="b27-ijms-11-02188"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>KJ</given-names></name><name><surname>Jeong</surname><given-names>YJ</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Kwon</surname><given-names>TK</given-names></name></person-group><article-title>Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells</article-title><source>Biochem. Biophys. Res. Commun</source><year>2004</year><volume>325</volume><fpage>1215</fpage><lpage>1222</lpage><pub-id pub-id-type="pmid">15555556</pub-id></mixed-citation></ref><ref id="b28-ijms-11-02188"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>KJ</given-names></name><name><surname>Yoo</surname><given-names>YH</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Kwon</surname><given-names>TK</given-names></name></person-group><article-title>Bcl-2 attenuates anti-cancer agents-induced apoptosis by sustained activation of Akt/protein kinase B in U937 cells</article-title><source>Apoptosis</source><year>2005</year><volume>10</volume><fpage>1333</fpage><lpage>1343</lpage><pub-id pub-id-type="pmid">16215670</pub-id></mixed-citation></ref><ref id="b29-ijms-11-02188"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>SJ</given-names></name><name><surname>Yoon</surname><given-names>JH</given-names></name><name><surname>Song</surname><given-names>KS</given-names></name></person-group><article-title>Chrysin inhibited stem cell factor (SCF)/c-Kit complex-induced cell proliferation in human myeloid leukemia cells</article-title><source>Biochem. Pharmacol</source><year>2007</year><volume>74</volume><fpage>215</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">17493588</pub-id></mixed-citation></ref><ref id="b30-ijms-11-02188"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>AM</given-names></name><name><surname>Aller</surname><given-names>P</given-names></name></person-group><article-title>Quercetin decreases intracellular GSH content and potentiates the apoptotic action of the anti-leukemic drug arsenic trioxide in human leukemia cell lines</article-title><source>Biochem. Pharmacol</source><year>2008</year><volume>75</volume><fpage>1912</fpage><lpage>1923</lpage><pub-id pub-id-type="pmid">18359480</pub-id></mixed-citation></ref><ref id="b31-ijms-11-02188"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>XH</given-names></name><name><surname>Wang</surname><given-names>ZJ</given-names></name></person-group><article-title>Flavones and flavonols exert cytotoxic effects on a human oesophageal adenocarcinoma cell line (OE33) by causing G2/M arrest and inducing apoptosis</article-title><source>Food Chem. Toxicol</source><year>2008</year><volume>46</volume><fpage>2042</fpage><lpage>2053</lpage><pub-id pub-id-type="pmid">18331776</pub-id></mixed-citation></ref><ref id="b32-ijms-11-02188"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Q</given-names></name><name><surname>Zhao</surname><given-names>XH</given-names></name><name><surname>Wang</surname><given-names>ZJ</given-names></name></person-group><article-title>Cytotoxicity of flavones and flavonols to a human esophageal squamous cell carcinoma cell line (KYSE-510) by induction of G2/M arrest and apoptosis</article-title><source>Toxicol. In Vitro</source><year>2009</year><volume>23</volume><fpage>797</fpage><lpage>807</lpage><pub-id pub-id-type="pmid">19397994</pub-id></mixed-citation></ref><ref id="b33-ijms-11-02188"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>HW</given-names></name><name><surname>Lin</surname><given-names>CP</given-names></name><name><surname>Chiu</surname><given-names>JH</given-names></name><name><surname>Chow</surname><given-names>KC</given-names></name><name><surname>Kuo</surname><given-names>KT</given-names></name><name><surname>Lin</surname><given-names>CS</given-names></name><name><surname>Wang</surname><given-names>LS</given-names></name></person-group><article-title>Reversal of inflammation-associated dihydrodiol dehydrogenases (AKR1C1 and AKR1C2) overexpression and drug resistance in nonsmall cell lung cancer cells by wogonin and chrysin</article-title><source>Int. J. Cancer</source><year>2007</year><volume>120</volume><fpage>2019</fpage><lpage>2027</lpage><pub-id pub-id-type="pmid">17266043</pub-id></mixed-citation></ref><ref id="b34-ijms-11-02188"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name><name><surname>VanAlstyne</surname><given-names>PC</given-names></name><name><surname>Irons</surname><given-names>KA</given-names></name><name><surname>Chen</surname><given-names>S</given-names></name><name><surname>Stewart</surname><given-names>JW</given-names></name><name><surname>Birt</surname><given-names>DF</given-names></name></person-group><article-title>Individual and interactive effects of apigenin analogs on G2/M cell-cycle arrest in human colon carcinoma cell lines</article-title><source>Nutr. Cancer</source><year>2004</year><volume>48</volume><fpage>106</fpage><lpage>114</lpage><pub-id pub-id-type="pmid">15203384</pub-id></mixed-citation></ref><ref id="b35-ijms-11-02188"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>X</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Ong</surname><given-names>CN</given-names></name><name><surname>Yang</surname><given-names>XF</given-names></name><name><surname>Shen</surname><given-names>HM</given-names></name></person-group><article-title>Chrysin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells via suppression of nuclear factor&#x02013;&#x003ba;B</article-title><source>Cancer Lett</source><year>2010</year><volume>293</volume><fpage>109</fpage><lpage>116</lpage><pub-id pub-id-type="pmid">20133051</pub-id></mixed-citation></ref><ref id="b36-ijms-11-02188"><label>36.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>Roberts</surname><given-names>R</given-names></name></person-group><source>Apoptosis in Toxicology</source><publisher-name>Taylor &#x00026; Francis</publisher-name><publisher-loc>London, UK</publisher-loc><year>2000</year><fpage>22</fpage><lpage>40</lpage><fpage>214</fpage><lpage>232</lpage></mixed-citation></ref><ref id="b37-ijms-11-02188"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kelekar</surname><given-names>A</given-names></name><name><surname>Chang</surname><given-names>BS</given-names></name><name><surname>Harlan</surname><given-names>JE</given-names></name><name><surname>Fesik</surname><given-names>SW</given-names></name><name><surname>Thompson</surname><given-names>CB</given-names></name></person-group><article-title>Bad is a BH3 domain-containing protein that forms an inactivating dimer with Bcl-XL</article-title><source>Mol. Cell Biol</source><year>1997</year><volume>17</volume><fpage>7040</fpage><lpage>7046</lpage><pub-id pub-id-type="pmid">9372935</pub-id></mixed-citation></ref><ref id="b38-ijms-11-02188"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pelengaris</surname><given-names>S</given-names></name><name><surname>Khan</surname><given-names>M</given-names></name><name><surname>Evan</surname><given-names>G</given-names></name></person-group><article-title>c-MYC: More than just a matter of life and death</article-title><source>Nat. Rev. Cancer</source><year>2002</year><volume>2</volume><fpage>764</fpage><lpage>776</lpage><pub-id pub-id-type="pmid">12360279</pub-id></mixed-citation></ref><ref id="b39-ijms-11-02188"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Debatin</surname><given-names>KM</given-names></name></person-group><article-title>Apoptosis pathways in cancer and cancer therapy</article-title><source>Cancer Immunol. Immunother</source><year>2004</year><volume>53</volume><fpage>153</fpage><lpage>159</lpage><pub-id pub-id-type="pmid">14749900</pub-id></mixed-citation></ref><ref id="b40-ijms-11-02188"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Hirose</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Yamada</surname><given-names>Y</given-names></name><name><surname>Kuno</surname><given-names>T</given-names></name><name><surname>Kohno</surname><given-names>H</given-names></name><name><surname>Katayama</surname><given-names>M</given-names></name><name><surname>Qiao</surname><given-names>Z</given-names></name><name><surname>Sakata</surname><given-names>K</given-names></name><name><surname>Sugie</surname><given-names>S</given-names></name><name><surname>Shibata</surname><given-names>T</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name></person-group><article-title>Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide</article-title><source>Cancer Sci</source><year>2003</year><volume>94</volume><fpage>365</fpage><lpage>371</lpage><pub-id pub-id-type="pmid">12824906</pub-id></mixed-citation></ref><ref id="b41-ijms-11-02188"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cogulu</surname><given-names>O</given-names></name><name><surname>Biray</surname><given-names>C</given-names></name><name><surname>Gunduz</surname><given-names>C</given-names></name><name><surname>Karaca</surname><given-names>E</given-names></name><name><surname>Aksoylar</surname><given-names>S</given-names></name><name><surname>Sorkun</surname><given-names>K</given-names></name><name><surname>Salih</surname><given-names>B</given-names></name><name><surname>Ozkinay</surname><given-names>F</given-names></name></person-group><article-title>Effects of Manisa propolis on telomerase activity in leukemia cells obtained from the bone marrow of leukemia patients</article-title><source>Int. J. Food Sci. Nutr</source><year>2009</year><volume>60</volume><fpage>601</fpage><lpage>605</lpage><pub-id pub-id-type="pmid">19817639</pub-id></mixed-citation></ref><ref id="b42-ijms-11-02188"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Josipovic</surname><given-names>P</given-names></name><name><surname>Orsolic</surname><given-names>N</given-names></name></person-group><article-title>Cytotoxicity of polyphenolic/flavonoid compounds in a leukaemia cell culture</article-title><source>Arh. Hig. Rada. Toksikol</source><year>2008</year><volume>59</volume><fpage>299</fpage><lpage>308</lpage><pub-id pub-id-type="pmid">19064369</pub-id></mixed-citation></ref><ref id="b43-ijms-11-02188"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ozmen</surname><given-names>A</given-names></name><name><surname>Madlener</surname><given-names>S</given-names></name><name><surname>Bauer</surname><given-names>S</given-names></name><name><surname>Krasteva</surname><given-names>S</given-names></name><name><surname>Vonach</surname><given-names>C</given-names></name><name><surname>Giessrigl</surname><given-names>B</given-names></name><name><surname>Gridling</surname><given-names>M</given-names></name><name><surname>Viola</surname><given-names>K</given-names></name><name><surname>Stark</surname><given-names>N</given-names></name><name><surname>Saiko</surname><given-names>P</given-names></name><name><surname>Michel</surname><given-names>B</given-names></name><name><surname>Fritzer-Szekeres</surname><given-names>M</given-names></name><name><surname>Szekeres</surname><given-names>T</given-names></name><name><surname>Askin-Celik</surname><given-names>T</given-names></name><name><surname>Krenn</surname><given-names>L</given-names></name><name><surname>Krupitza</surname><given-names>G</given-names></name></person-group><article-title><italic>In vitro</italic> anti-leukemic activity of the ethno-pharmacological plant Scutellaria orientalis ssp. carica endemic to western Turkey</article-title><source>Phytomedicine</source><year>2010</year><volume>17</volume><fpage>55</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">19576743</pub-id></mixed-citation></ref><ref id="b44-ijms-11-02188"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chang</surname><given-names>H</given-names></name><name><surname>Mi</surname><given-names>MT</given-names></name><name><surname>Gu</surname><given-names>YY</given-names></name><name><surname>Yuan</surname><given-names>JL</given-names></name><name><surname>Ling</surname><given-names>WH</given-names></name><name><surname>Lin</surname><given-names>H</given-names></name></person-group><article-title>Effects of flavonoids with different structures on proliferation of leukemia cell line HL-60</article-title><source>Chin. J. Cancer</source><year>2007</year><volume>26</volume><fpage>1309</fpage><lpage>1314</lpage></mixed-citation></ref><ref id="b45-ijms-11-02188"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Woo</surname><given-names>KJ</given-names></name><name><surname>Jeong</surname><given-names>YJ</given-names></name><name><surname>Inoue</surname><given-names>H</given-names></name><name><surname>Park</surname><given-names>JW</given-names></name><name><surname>Kwon</surname><given-names>TK</given-names></name></person-group><article-title>Chrysin suppresses lipopolysaccharide-induced cyclooxygenase-2 expression through the inhibition of nuclear factor for IL-6 (NF-IL6) DNA-binding activity</article-title><source>FEBS Lett</source><year>2005</year><volume>579</volume><fpage>705</fpage><lpage>711</lpage><pub-id pub-id-type="pmid">15670832</pub-id></mixed-citation></ref><ref id="b46-ijms-11-02188"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>HZ</given-names></name><name><surname>Cao</surname><given-names>JG</given-names></name><name><surname>Deng</surname><given-names>YA</given-names></name><name><surname>Xu</surname><given-names>JH</given-names></name><name><surname>Xie</surname><given-names>WY</given-names></name></person-group><article-title>Induction of apoptosis of human ovarian cancer CoC1 cells by 5-allyl-7-gen-difluoromethylenechrysin through activation of peroxisome-proliferator activated receptor-gamma</article-title><source>Chin. Med. Assoc. J</source><year>2007</year><volume>87</volume><fpage>2914</fpage><lpage>2918</lpage></mixed-citation></ref><ref id="b47-ijms-11-02188"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ai</surname><given-names>XH</given-names></name><name><surname>Zheng</surname><given-names>X</given-names></name><name><surname>Tang</surname><given-names>XQ</given-names></name><name><surname>Sun</surname><given-names>L</given-names></name><name><surname>Zhang</surname><given-names>YQ</given-names></name><name><surname>Qin</surname><given-names>Y</given-names></name><name><surname>Liu</surname><given-names>HQ</given-names></name><name><surname>Xia</surname><given-names>H</given-names></name><name><surname>Cao</surname><given-names>JG</given-names></name></person-group><article-title>Induction of apoptosis of human gastric carcinoma SGC-7901 cell line by 5, 7-dihydroxy-8-nitrochrysin <italic>in vitro</italic></article-title><source>World J. Gastroenterol</source><year>2007</year><volume>13</volume><fpage>3824</fpage><lpage>3828</lpage><pub-id pub-id-type="pmid">17657836</pub-id></mixed-citation></ref></ref-list></back><floats-group><fig id="f1-ijms-11-02188" position="float"><label>Figure 1.</label><caption><p>(<bold>A</bold>) Common chemical structure of flavones. Flavones have a common chemical structure consisting of fused A and C rings, and a phenyl B ring attached to position 2 of the C ring. (<bold>B</bold>) Chrysin is in the flavone subgroup of flavonoids and shares a common flavone structure with hydroxyls at position 5 and 7 of the A ring. Replacing the hydroxyl with a phosphate group at position 7, such as in diethyl chrysin-7-yl phosphate (CPE). (<bold>C</bold>) or at positions 5 and 7, such as in tetraethyl bis-phosphoric ester of chrysin (CP). (<bold>D</bold>), enhances the anti-cancer potential of the chrysin.</p></caption><graphic xlink:href="ijms-11-02188f1"/></fig><fig id="f2-ijms-11-02188" position="float"><label>Figure 2.</label><caption><p>The PI3K/Akt signaling pathway. Chrysin is likely to act via activation of caspases and inactivation of Akt signaling in leukemia cells. (&#x02022;) depicts chrysin.</p></caption><graphic xlink:href="ijms-11-02188f2"/></fig><table-wrap id="t1-ijms-11-02188" position="float"><label>Table 1.</label><caption><p>The apoptotic effects of chrysin in human cervical cancer, leukemia, esophageal squamous carcinoma, malignant glioma, breast carcinoma and prostate cancer <italic>in vitro</italic>.</p></caption><table frame="hsides" rules="rows"><thead><tr><th align="center" valign="bottom" rowspan="1" colspan="1"><bold>Cancer type</bold></th><th align="center" valign="bottom" rowspan="1" colspan="1"><bold>Reference</bold></th><th align="center" valign="bottom" rowspan="1" colspan="1"><bold>Effect and molecular mechanism</bold></th></tr></thead><tbody><tr><td align="center" valign="middle" rowspan="2" colspan="1"><bold>Cervical cancer</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b24-ijms-11-02188">24</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin (IC<sub>50</sub> = 14.2 &#x003bc;M) inhibited proliferation and induced apoptosis in HeLa cells, though the effects were not as potent as those of its synthetic derivative compounds.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b25-ijms-11-02188">25</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin (30 &#x003bc;M) potentially induced p38 and NFkappaB/p65 activation in HeLa cells.</td></tr><tr><td align="center" valign="middle" rowspan="4" colspan="1"><bold>Leukemia</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b26-ijms-11-02188">26</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin (IC<sub>50</sub> = 16 &#x003bc;M) showed to be the most potent flavonoid to reduce cell viability and induce apoptotic DNA fragmentation in U937 cells.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b27-ijms-11-02188">27</xref>,<xref ref-type="bibr" rid="b28-ijms-11-02188">28</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin induced apoptosis in Bcl-2 overexpressing U937 leukemia cells, was associated with activation of caspase-3 and PLC-&#x003b3;1 degradation. The induction of apoptosis was accompanied by down-regulation of XIAP and inactivation of Akt.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b29-ijms-11-02188">29</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin had the ability to abolish SCF/c-Kit signaling by inhibiting the PI3K pathway in MO7e, myeloid leukemia cells.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b30-ijms-11-02188">30</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin, alone or in combination with other compounds, decreased Akt phosphorylation and potentially caused mitochondrial dysfunction in THP-1 and HL-60 leukemia cells.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Esophageal squamous carcinoma</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b31-ijms-11-02188">31</xref>,<xref ref-type="bibr" rid="b32-ijms-11-02188">32</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin (IC<sub>50</sub> = 63 &#x003bc;M) induced cytotoxicity in KYSE-510 cells in dose- and time-dependent manners.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Malignant glioma, breast carcinoma, prostate cancer</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b11-ijms-11-02188">11</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin (100 &#x003bc;M) showed dose-dependent inhibition of U87-MG, MDA-MB-231, U-251 and PC3 proliferation, and displayed apoptotic activity in U87-MG cells. However, the study did not report details about the apoptotic activity of chrysin in U-251, MDA-MB-231 and PC3 cells.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>NSCLC</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b33-ijms-11-02188">33</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin and wogonin showed to have potential as adjuvant therapy for drug-resistant NSCLC, especially in patients with AKR1C1/1C2 overexpression where IL-6-induced AKR1C1/1C2 overexpression and drug resistance could be inhibited by these flavonoids in H23 cells.</td></tr><tr><td align="center" valign="middle" rowspan="1" colspan="1"><bold>Colon cancer</bold></td><td align="center" valign="middle" rowspan="1" colspan="1">[<xref ref-type="bibr" rid="b34-ijms-11-02188">34</xref>]</td><td align="left" valign="middle" rowspan="1" colspan="1">Chrysin caused the SW480 cells in cell-cycle arrest at the G2/M phase in a dose-dependent manner.</td></tr></tbody></table></table-wrap></floats-group></article>